Neuroprotective Effects of Phosphodiesterase Inhibitors on Sestrin-2 (SESN2) Expression and Autophagy in Alzheimer’s Disease Model. The gene discussed is SESN2; the disease is early-onset autosomal dominant Alzheimer disease.